Professional Documents
Culture Documents
5 Nitro
5 Nitro
The average calculated bond length C1-N2 in the the phenolic hydroxyl group [32–35]. Deprotonation
three 5-nitro-compounds is 1.289 Ǻ, very close to equilibrium between the neutral and the
the experimentally measured one for SBH (1.291 Ǻ) deprotonated form occurs in weak basic medium
and perfectly matches the length of the double bond (Scheme 2) and the phenolic hydroxyl group loses
C = N equal to 1.29 Ǻ. The calculated length of the its proton [36].
bond N3-C4 is slightly above that experimentally In general, the most negative value of the
determined for 5nSBH and SBH, whereas the electrostatic potential in the neutral molecules LH is
average calculated distance N2-N3 (1.355 Ǻ) is focused on the carbonyl oxygen O11, whereas the
slightly shorter than the experimental one in 5nSBH other donor atoms have a higher, even positive value
(1.382 Ǻ). An excellent match exists between the of the electrostatic potential. So it is practically
experimentally measured and calculated distances of impossible to realize a complex compound with the
the carbonyl group C4-O11 for the three compounds neutral forms of the hydrazones. Deprotonation of
(1.221 Ǻ) and the typical length of a double bond C О9 brings about considerably negative values of the
= O (1.22 Ǻ). electrostatic potential for it, as well as the
The values of the calculated angles are very close appearance of such over N2. Appearance of a NO2-
to the experimentally measured ones and reveal that group in the salicylaldehyde moiety slightly
all carbon atoms are in sp2 hybridization. Minor increases the value of the electrostatic potential,
differences of about ± 3 ° were observed in the probably due to its negative inductive effect.
calculated angles C1-N2-N3, N3-C4-C5 and C5-C4- In view of these observations it can be concluded
O11. that the hydroxyl oxygen atom О9, the imine
Despite the small differences obtained, the nitrogen atom N2 and the carbonyl oxygen atom
optimized geometries of nitro-hydrazones are in О11 will be the preferred sites for complex
good agreement with the experimental electron formation with metal ions. Compounds 5nSBH and
diffraction data. The substituents at the 4th position 5nSIH will have similar activity like SBH, 5nShBH
in the hydrazide ring insignificantly affect the bond being the most potent chelating agent among the new
lengths and angles and all 5-nitrosalicylaldehyde compounds.
hydrazone derivatives have similar geometry. The The nitro-group withdraws electron density from
optimized structures of the 5-nitro derivatives are the aldehyde ring, thus the replacement of the
presented in Fig.2. hydrogen in SBH with a nitro group in nitro-
Aroylhydrazones can act as polydentate ligands derivatives will result in partially positive charges at
depending on the reaction conditions, the nature of ortho- and para-positions. Additionally, this will
metal ion and hydrazone ligand, and the pH of the increase the polarity of the phenolic group on para-
medium. Salicylaldehyde benzoylhydrazone and its position and will influence and facilitate its
substituted derivatives have four donor atoms N2, deprotonation during complexation.
N3, O9 and O11 which allow binding to a central To predict the reactivity of the new hydrazones
metal ion in a versatile manner. However, in most of as iron-chelators, MEP was calculated. The negative
their complex compounds, they react as tridentate regions in the molecules with negative values of
ligands in mono-anionic form after deprotonation of electrostatic potential were related to the
803
B. I. Nikolova-Mladenova, S. E. Angelova: Synthesis of 5-nitrosalicylaldehyde based hydrazones and DFT-calculations of …
electrophilic reactivity and were found as the
reactive sites where the metal ion will prefer to
coordinate. An approaching iron ion will be attracted
to the region of the molecule with the most negative
values, i.e., where the effects of the electrons are
dominant [24]. Table 2 presents recently calculated
minima of the molecular electrostatic potentials Vmin
for the nitro-derivatives, compared with these of
SBH [37]. Both of the oxygen atoms - O9 and
O11 have two values of the electrostatic
potential due to the presence of two electron
pairs around them. The values for O9 in the
neutral form LH are identical and only one is
shown.
CONCLUSIONS
In conclusion, three hydrazones, 5-
nitroderivatives of salicylaldehyde benzoyl
hydrazone were synthesized. The molecular
formulas of the substances were confirmed by
elemental, thermogravimetric and spectral analyses
such as IR, 1H NMR and 13C NMR. Computational
studies were carried out in order to evaluate the
molecular structure. The substitutions in the
Fig. 2. B3LYP/6-31+G (d,p) optimized structures of aromatic nuclei insignificantly influenced the
5nSBH, 5nShBH and 5nSIH. geometries and all derivatives have similar structure.
The DFT-calculated molecular electrostatic
potentials for all molecules indicate the favorable
sites for iron chelation - hydroxyl oxygen atom,
imine nitrogen atom and carbonyl oxygen atom.
804
B. I. Nikolova-Mladenova, S. E. Angelova: Synthesis of 5-nitrosalicylaldehyde based hydrazones and DFT-calculations of …
REFERENCES 20. B. Nikolova-Mladenova, N. Halachev, R. Iankova, G.
Momekov, D. Ivanov, Arzneim.-Forsch., 61(12), 714
1. Z. A. Kaplancikli, M. D. Altintop, A. Ozdemir, G.
(2011).
Turan-Zitouni, S. I. Khan, N. Tabanca, Lett. Drug
21. А. D. Becke, J. Chem. Phys., 98, 5648 (1993).
Des. Discovery, 9, 310 (2012).
22. С. Lee, W. Yang, R. G. Parr, Phys. Rev. B, 37, 785
2. W. B. Júnior, M. S. Alexandre-Moreira, M. A. Alves,
(1998).
A. Perez-Rebolledo, G. L. Parrilha, E. E. Castellano,
23. M. Frisch, G. W. Trucks, H. B. Schlegel, G. E.
O. E. Piro, E. J. Barreiro, L. M. Lima, H. Beraldo,
Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani,
Molecules 16, 6902 (2011).
V. Barone, B. Mennucci, G. A. Petersson, H.
3. A. Ozdemir, G. Turan-Zitouni, Z. A. Kaplancikli, G.
Nakatsuji. Gaussian 09, revision A. 02; Gaussian, Inc.
Revial, Marm. Pharm. J., 14, 79 (2010).
Wallingford, CT, 19, p. 227 (2009).
4. B. Koçyiğit-Kaymakçıoğlu, E. E. Oruç-Emre, S.
24. Р. Politzer, J. S. Murray, in: K. B. Lipkowitz, D. B.
Unsalan, S. Rollas, Med. Chem. Res., 18, 277 (2009).
Boyd (Eds.): Reviews in Computational Chemistry,
5. T. Govindasami, A. Pandey, N. Palanivelu, A. Pandey,
vol. 2, VCH Publishers, New York, 1991, p. 273.
Int. J. Org. Chem., 1, 71 (2011).
25. Р Politzer, J. S. Murray, Theor. Chem. Acc., 108, 134
6. L. Savini, P. Massarelli, V. Travagli, C. Pellerano, E.
(2002).
Novellino, S. Cosentino, M. B. Pisano, Eur. J. Med.
26. C. Munoz-Caro, A. Nino, M. L. Senent, J. M. Leal, S.
Chem., 39, 113 (2004).
Ibeas, J. Org. Chem., 65, 405 (2000).
7. P. Vicini, M. Incerti, P.L. Colla, R.E. Loddo, Eur. J.
27. N. Okulik, A. H. Jubert, Internet Electron. J. Mol.
Med. Chem., 44, 1801 (2009).
Des., 4, 17 (2005).
8. T. B. Chaston, R. N. Watts, J. Yuan, D. R. Richardson,
28. R. Soliva, F. J. Luque, M. Orozco, Theor. Chem. Acc.,
Clin. Cancer Res., 10, 7365 (2004).
98, 42 (1997).
9. D. K. Johnson, T. B. Murphy, N. J. Rose, W. H.
29. J.T. Edward, M. Gauthier, F.L. Chubb, P. Ponka, J.
Goodwin, L. Pickart, Inorg. Chim. Acta, 67, 159
Chem. Eng. Data, 33, 538 (1988).
(1982).
30. A. Lyubchova, A. Cossé-Barbi, J.P. Doucet, Acta
10. J.T. Edward, BioMetals, 11, 203 (1998).
Cryst. C51, 1893 (1995).
11. J.T. Edward, P. Ponka, D.R. Richardson, BioMetals,
31. H. M. Ali, S. Puvaneswary, S. W. Ng, Acta Cryst.
8, 209 (1995).
E61, 3464 (2005).
12. E.M. Becker, D.R. Richardson, J. Lab. Clin. Med.,
32. R. M. El-Bahnasawy, S. E. El-Meleigy, A. El-
134, 510 (1999).
Tawansi, Trans. Met. Chem., 19, 270 (1994).
13. P. Ponka, D. Richardson, E. Baker, H. M. Schulman,
33. B. Mladenova, D. S. Ivanov, M. H. Umbreit, J. Klos,
J. T. Edward, Biochim. Biophys. Acta, 967, 122
S. Konstantinov, M. Karaivanova, Pharmacy, 3-4, 3
(1988).
(2003).
14. E. Baker, D. R. Richardson, S. Gross, P. Ponka,
34. B. Nikolova-Mladenova, D. Ivanov, Pharmacia,
Hepatology, 15, 492 (1992).
61(4), 7 (2014).
15. D. R. Richardson, P. Ponka , J. Lab. Clin. Med., 131,
35. S. A. Yasrebi, H. Mobasheri, I. Sheikhshoaie, M.
306 (1998).
Rahban, Inorg. Chim. Acta, 400, 222 (2013).
16. J. L. Buss, E. Arduini, P. Ponka, Biochem.
36. Yi-H. Lu, Yu-W. Lu, C.-Li Wu, Q. Shao, X.-L. Chen,
Pharmacol., 64, 1689 (2002).
R. Bimbong, Spectrochim. Acta Mol. Biomol.
17. D. B. Lovejoy, D. R. Richardson, Blood, 100, 666
Spectrosc., 65, 695 (2006).
(2002).
37. N.Halachev, R. Iankova, St. Manolov, B. Nikolova-
18. D. R. Richardson, K. Milnes, Blood, 89, 3025 (1997).
Mladenova, D. S. Ivanov, Annual Assen Zlatarov
19. D.R. Richardson, Antimicrob. Agents Chemother., 41,
University, XXXVI (1), 44 (2007).
2061 (1997).
805
B. I. Nikolova-Mladenova, S. E. Angelova: Synthesis of 5-nitrosalicylaldehyde based hydrazones and DFT-calculations of …
806